JAGUAR HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2867 USD | +12.39% |
|
-7.37% | +89.37% |
| 05-14 | Earnings Flash (JAGX) JAGUAR HEALTH Reports Q1 Revenue $2.4M, vs. Street Est of $3M | MT |
| 05-14 | Transcript : Jaguar Health, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Evolution of the average Target Price on Jaguar Health, Inc.
Price target over the last 5 years
History of analyst recommendation changes
adb3abac3d404e3.7tpKP3N4-3agiwbqvhotdcxR5EzIak1g_amrrn-HyVE.ircHfQdBuULDxGCw9XdJRYQUigakBQAJjp3HnQvvpBOqohNNCh7NI_b_Xw~a74e469d9fd80803b473711d1893f84d
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2867
USD
Average target price
0.6
USD
Spread / Average Target
+109.28%
High Price Target
0.6
USD
Spread / Highest target
+109.28%
Low Price Target
0.6
USD
Spread / Lowest Target
+109.28%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Jaguar Health, Inc.
| Cantor Fitzgerald |
EPS Revisions
- Stock Market
- Equities
- JAGX Stock
- Consensus Jaguar Health, Inc.
